Pharma Mar, S.A. (PHMMF)
OTCMKTS
· Delayed Price · Currency is USD
88.18
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
Pharma Mar Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 19.88 | 26.13 | 1.14 | 49.36 | 92.86 | 137.26 | Upgrade
|
| Depreciation & Amortization | 6.17 | 5.72 | 4.72 | 4.89 | 4.56 | 4.33 | Upgrade
|
| Other Amortization | 1.05 | 1.05 | 1.03 | 1.01 | 1.03 | 2.88 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.84 | -0.84 | 1.93 | -0.01 | 0.03 | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.28 | -0.28 | -1.75 | 1.48 | -0.18 | 0.37 | Upgrade
|
| Stock-Based Compensation | -0.01 | - | 0.3 | 0.39 | 0.34 | 0.27 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | - | 0.02 | Upgrade
|
| Other Operating Activities | 0.11 | 6 | 14.09 | 9.42 | -11.55 | 5.84 | Upgrade
|
| Change in Accounts Receivable | -9.84 | -7.32 | 1.78 | 21.61 | -26.76 | -12.63 | Upgrade
|
| Change in Inventory | -7.05 | -12.68 | -11.54 | -17.21 | 1.4 | -3.03 | Upgrade
|
| Change in Accounts Payable | 3.87 | 11.23 | 3.39 | 1.79 | 7.19 | 4.65 | Upgrade
|
| Change in Unearned Revenue | -25.92 | -24.93 | -23.2 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 3.32 | 1.95 | -5.34 | -34.41 | -43.23 | 138.95 | Upgrade
|
| Operating Cash Flow | -9.56 | 6.03 | -13.45 | 38.32 | 25.68 | 278.94 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 49.24% | -90.80% | - | Upgrade
|
| Capital Expenditures | -8.23 | -15.02 | -14.81 | -8.85 | -7.8 | -3 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.89 | 0.89 | - | 0.01 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.5 | -0.5 | -1.15 | - | - | - | Upgrade
|
| Investment in Securities | 47.17 | 15.66 | -27.09 | 19.72 | 26.28 | -116.01 | Upgrade
|
| Investing Cash Flow | 39.33 | 1.03 | -43.05 | 10.88 | 18.47 | -119.01 | Upgrade
|
| Long-Term Debt Issued | - | 15.41 | 7.2 | 1.54 | 5.83 | 0.83 | Upgrade
|
| Total Debt Issued | 17.53 | 15.41 | 7.2 | 1.54 | 5.83 | 0.83 | Upgrade
|
| Long-Term Debt Repaid | - | -9.56 | -8.36 | -10.2 | -15.27 | -32.37 | Upgrade
|
| Total Debt Repaid | -7.9 | -9.56 | -8.36 | -10.2 | -15.27 | -32.37 | Upgrade
|
| Net Debt Issued (Repaid) | 9.64 | 5.86 | -1.15 | -8.66 | -9.44 | -31.54 | Upgrade
|
| Issuance of Common Stock | 17.71 | 18.91 | 18.61 | 57.23 | 33.55 | 30.37 | Upgrade
|
| Repurchase of Common Stock | -21.3 | -18.63 | -37.9 | -50.18 | -40.66 | -63.71 | Upgrade
|
| Common Dividends Paid | -11.42 | -11.42 | -11.69 | -11.76 | -10.87 | -8.82 | Upgrade
|
| Other Financing Activities | -0.07 | -0.07 | - | - | - | -0.12 | Upgrade
|
| Financing Cash Flow | -5.43 | -5.35 | -32.14 | -13.37 | -27.42 | -73.82 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.25 | 1.51 | -1.16 | 0.64 | 0.4 | -7.54 | Upgrade
|
| Net Cash Flow | 24.58 | 3.22 | -89.79 | 36.47 | 17.14 | 78.57 | Upgrade
|
| Free Cash Flow | -17.79 | -8.99 | -28.25 | 29.47 | 17.87 | 275.94 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 64.87% | -93.52% | - | Upgrade
|
| Free Cash Flow Margin | -10.12% | -5.14% | -17.87% | 15.01% | 7.78% | 102.21% | Upgrade
|
| Free Cash Flow Per Share | - | -0.51 | -1.58 | 1.63 | 0.99 | 15.06 | Upgrade
|
| Cash Interest Paid | 2.53 | 2.47 | 2.42 | 2.38 | 3.37 | 3.12 | Upgrade
|
| Cash Income Tax Paid | - | -23.26 | -16.59 | -2.72 | 7.86 | 9.65 | Upgrade
|
| Levered Free Cash Flow | -23.91 | -20.15 | -12.59 | 33.11 | 4.75 | 128.41 | Upgrade
|
| Unlevered Free Cash Flow | -21.86 | -18.61 | -11.08 | 34.6 | 6.86 | 130.36 | Upgrade
|
| Change in Net Working Capital | 25.21 | 13.92 | -1.22 | -10.86 | 49.04 | -27.98 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.